Intratumoural heterogeneity measured using FDG PET and MRI is associated with tumour-stroma ratio and clinical outcome in head and neck squamous cell carcinoma

被引:24
|
作者
Choi, J. W. [1 ]
Lee, D. [2 ]
Hyun, S. H. [3 ]
Han, M. [1 ]
Kim, J. -H. [2 ]
Lee, S. J. [4 ]
机构
[1] Ajou Univ, Sch Med, Dept Radiol, Suwon, South Korea
[2] Ajou Univ, Sch Med, Dept Pathol, Suwon, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Nucl Med, Seoul, South Korea
[4] Ajou Univ, Sch Med, Dept Nucl Med, 164 Worldcup Ro, Suwon 16499, South Korea
基金
新加坡国家研究基金会;
关键词
APPARENT DIFFUSION-COEFFICIENT; F-18-FDG UPTAKE; INVASIVE COMPONENTS; SURVIVAL; CANCER; PARAMETERS; PREDICTOR;
D O I
10.1016/j.crad.2017.01.019
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
AIM: To evaluate the association between the tumourestroma ratio and intratumoural heterogeneity measured using 2-[F-18]-fluoro-2-deoxy-D-glucose (FDG) positron-emission tomography (PET) and magnetic resonance imaging (MRI), and further investigate the prognostic significance of imaging biomarkers in head and neck squamous cell carcinoma (HNSCC). MATERIALS AND METHODS: Textural-based imaging parameters of the primary tumour were extracted in 44 patients. In addition, the difference between the minimum and maximum apparent diffusion coefficient (ADC) values (ADCdiff) was calculated on MRI. The relationships between the tumourestroma ratio and imaging parameters were evaluated. The associations between imaging parameters and recurrence-free survival (RFS) were assessed using Cox proportional hazard regression models. RESULTS: Coarseness (r = -0.382) on PET and ADCdiff (r = 0.534) on MRI were significantly correlated with the proportion of stroma. The best imaging biomarkers for the 2-year RFS prediction were coarseness (AUC = 0.741) and ADCdiff (AUC = 0.779). Multivariate analysis showed that coarseness (hazard ratio = 10.549, 95% confidence interval = 2.544-43.748, p = 0.001) was an independent prognostic factor for RFS. CONCLUSION: Heterogeneity imaging parameters are significantly associated with the tumourestroma ratio. These imaging biomarkers may help to facilitate the risk stratification for tumour recurrence in HNSCC. (C) 2017 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:482 / 489
页数:8
相关论文
共 50 条
  • [1] Tumour-stroma ratio is a valuable prognostic factor for oral tongue squamous cell carcinoma
    Kang, Jia
    Su, Ming
    Xu, Qiaoshi
    Wang, Chong
    Yuan, Xiaohong
    Han, Zhengxue
    ORAL DISEASES, 2023, 29 (02) : 628 - 638
  • [2] Immunohistochemical biomarkers and FDG uptake on PET/CT in head and neck squamous cell carcinoma
    Rasmussen, Gregers Brunnich
    Vogelius, Ivan R.
    Rasmussen, Jacob H.
    Schumaker, Lisa
    Ioffe, Olga
    Cullen, Kevin
    Fischer, Barbara Malene
    Therkildsen, Marianne Hamilton
    Specht, Lena
    Bentzen, Soren M.
    ACTA ONCOLOGICA, 2015, 54 (09) : 1408 - 1415
  • [3] Locoregional tumour evaluation of squamous cell carcinoma in the head and neck area: a comparison between MRI, PET/CT and integrated PET/MRI
    Schaarschmidt, Benedikt Michael
    Heusch, Philipp
    Buchbender, Christian
    Ruhlmann, Marcus
    Bergmann, Christoph
    Ruhlmann, Verena
    Schlamann, Marc
    Antoch, Gerald
    Forsting, Michael
    Wetter, Axel
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (01) : 92 - 102
  • [4] Clinical value of 18FDG PET/CT in screening for distant metastases in head and neck squamous cell carcinoma
    Deurvorst, S. E.
    Hoekstra, O. S.
    Castelijns, J. A.
    Witte, B. I.
    Leemans, C. R.
    de Bree, R.
    CLINICAL OTOLARYNGOLOGY, 2018, 43 (03) : 875 - 881
  • [5] A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma
    Shaban, Muhammad
    Raza, Shan E. Ahmed
    Hassan, Mariam
    Jamshed, Arif
    Mushtaq, Sajid
    Loya, Asif
    Batis, Nikolaos
    Brooks, Jill
    Nankivell, Paul
    Sharma, Neil
    Robinson, Max
    Mehanna, Hisham
    Khurram, Syed Ali
    Rajpoot, Nasir
    JOURNAL OF PATHOLOGY, 2022, 256 (02) : 174 - 185
  • [6] FDG PET/CT for metastatic squamous cell carcinoma of unknown primary of the head and neck
    Liu, Yiyan
    ORAL ONCOLOGY, 2019, 92 : 46 - 51
  • [7] 18F-FDG PET/CT and MRI in the follow-up of head and neck squamous cell carcinoma
    Ghanooni, Rose
    Delpierre, Isabelle
    Magremanne, Michele
    Vervaet, Catherine
    Dumarey, Nicolas
    Remmelink, Myriam
    Lacroix, Simon
    Trotta, Nicola
    Hassid, Sergio
    Goldman, Serge
    CONTRAST MEDIA & MOLECULAR IMAGING, 2011, 6 (04) : 260 - 266
  • [8] Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures
    Mes, Steven W.
    van Velden, Floris H. P.
    Peltenburg, Boris
    Peeters, Carel F. W.
    te Beest, Dennis E.
    van de Wiel, Mark A.
    Mekke, Joost
    Mulder, Doriene C.
    Martens, Roland M.
    Castelijns, Jonas A.
    Pameijer, Frank A.
    de Bree, Remco
    Boellaard, Ronald
    Leemans, C. Rene
    Brakenhoff, Ruud H.
    de Graaf, Pim
    EUROPEAN RADIOLOGY, 2020, 30 (11) : 6311 - 6321
  • [9] μ-Crystallin Is Associated with Disease Outcome in Head and Neck Squamous Cell Carcinoma
    Jank, Bernhard J.
    Haas, Markus
    Schnoell, Julia
    Schlederer, Michaela
    Heiduschka, Gregor
    Kenner, Lukas
    Kadletz-Wanke, Lorenz
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (12):
  • [10] Single-cell spatial architectures associated with clinical outcome in head and neck squamous cell carcinoma
    Blise, Katie E.
    Sivagnanam, Shamilene
    Banik, Grace L.
    Coussens, Lisa M.
    Goecks, Jeremy
    NPJ PRECISION ONCOLOGY, 2022, 6 (01)